|
Dr. Vehar is an expert in protein chemistry with extensive experience in protein purification and identification technologies and particular expertise in antigen identification. Prior to joining Raven, he was with Genentech for 20 years in various roles, including Director of Cardiovascular Research and Staff Scientist for Cardiovascular Research and for Protein Chemistry. Dr. Vehar served as Project Team Leader on six drug discovery and development projects that yielded four Genentech products currently on the market. Dr. Vehar is the recipient of the Murray Thelin Award for Outstanding Research presented by the National Hemophilia Foundation, the Inventor of the Year Award given by Intellectual Property Owners, Inc. for the human tissue plasminogen activator (t-PA) patent, and the Distinguished Inventor of the Year Award from Intellectual Property Owners, Inc. for the patent on recombinant Factor VIII, a genetically engineered clotting factor that enabled production of a therapeutic product for treating hemophilia A patients that is free of HIV and hepatitis contamination. He has served on the Scientific Advisory Board for the Oklahoma Center for Molecular Medicine. Dr. Vehar is an inventor on 37 issued patents and has authored more than 35 publications. He received a PhD from the University of Cincinnati Medical School. | 